Advanced Medical Institute (AMI)
AMI Australia is a leading provider of treatment programs for erectile dysfunction (ED) and premature ejaculation (PE) in Australasia. AMI has more than 350 employees, including 50 medical personnel and, since its inception, has provided treatment or counselling to more than 300,000 patients. Advanced Medical Institute and its predecessor companies began treating premature ejaculation and erectile dysfunction patients in 1993.
Advanced Medical Institute (AMI), will launch a bold and direct billboard campaign across 196 sites across London, emblazoned with the slogan "Want Longer Lasting Sex?" targeted at men and women who suffer with problems of sexual dysfunction. Understanding the sensitivity and embarrassment which often surrounds the issue of sexual performance, AMI Australia have designed their service so that you do not have to visit their Harley Street Clinic unless you want to; offering the alternative of a free and discreet consultation over the phone. Patients are able to speak to a specialist doctor, who will prescribe one of AMI Australia specifically tailored treatments.
Advanced Medical Institute (AMI) provide revolutionary treatments for people suffering from premature ejaculation and erectile dysfunction. Their innovative technology, which includes a nasal delivery option, has already helped over 400,000 people overcome problems with sexual performance in Australia and New Zealand.
Jack Vaisman is a pioneer in the direct marketing impotency businesses in Australia. Since 2001, he has served as the managing director and chief executive officer of Advanced Medical Institute (AMI). He is responsible for the overall management and strategic direction of AMI Australia's impotency operations with the support of AMI Australia's chief operations officer, Tony Khan, and AMI's chief financial officer, Dilip Shrestha. Vaisman was also the founder and director of On Clinic International in Australia, a predecessor of Advanced Medical Institute (AMI). The holder of a Bachelor of Medicine, a Master of Gynaecology and a Ph.D. in Medical Science, he has more than 35 years of experience and expertise in the field of sexual health care provision and was recently granted an innovation patent in the field of ED and PE treatment by the Australian patent office.
"I am very pleased to announce that our Board has secured Jack's long term commitment to continuing as an executive of Advanced Medical Institute (AMI), our core operational business. Jack has been instrumental to the success of our business and his outstanding performance as the chief executive of our company has been integral to the group's success. His strategic vision, organizational abilities and operational expertise have been major factors in our growing success in the Australian market during the past four years," stated Khan.
"I look forward to continuing to lead Advanced Medical Institute (AMI) in the coming years," said Vaisman. "We are all excited by the opportunities to grow and expand our core business in Australia and overseas and by the outlook for new and promising new treatment delivery methods currently being developed by (AMI),".
AMI nasal Spray developed and patented by the Advanced Medical Institute (AMI) of Australia. AMI are also based in New Zealand and now Europe under amieurope.co.uk. The nasal sprays developed by this company have been under a lot of scrutiny lately and this adds to all the controversy the company as a whole has attracted since its inception in Australia. Advanced Medical Institute (AMI) will now conduct business in the UK through its wholly owned subsidiary, AMI Clinic Limited (AVMD UK).
